M&A
Syngenta rejects Monsanto's latest offer
Syngenta has rejected a second takeover offer from Monsanto Co, saying that the newly-introduced breakup fee added to the original offers terms was “wholly inadequate”.
Allergy Therapeutics buys Alerpharma for 3.8m euros
Specialty pharmaceutical company Allergy Therapeutics said on Friday that it has agreed to buy Alerpharma SA for an initial consideration of €3. 8m.
BASF said to be mulling bid for Syngenta
German chemicals group BASF SE is reportedly mulling an offer for Swiss rival Syngenta, potentially putting itself forward as a rival to Monsanto.
Dish Network reportedly in merger talks with T-Mobile US
Dish Network Corp is reportedly in talks to merge with T-Mobile US, in a deal that would accelerate a wave of consolidation across the US media and communications industries.
Delhaize, Ahold merger talks said to be progressing
Merger talks between supermarket groups Delhaize and Royal Ahold NV are reportedly progressing well, with the goal of reaching an agreement by the end of this month.
Playtech acquires troubled Plus500 in £459.6m cash deal
Spread betting firm Plus500 has been snapped up by FTSE 250 listed gaming company Playtech in a £459. 6m cash deal.
Intel reportedly nears deal to buy Altera for $54 a share
Intel is reportedly close to acquiring Altera for as much as $17bn, or roughly $54 a share, in what would be the tech company’s largest deal ever.